Benoît Lamarche Selected Research

Apolipoprotein B-48

6/2017	The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels.
1/2016	n-3 Polyunsaturated Fatty Acid Supplementation Has No Effect on Postprandial Triglyceride-Rich Lipoprotein Kinetics in Men with Type 2 Diabetes.
1/2014	Dietary medium-chain triglyceride supplementation has no effect on apolipoprotein B-48 and apolipoprotein B-100 kinetics in insulin-resistant men.
2/2008	Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.
6/2007	Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes.
6/2006	Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans.
5/2006	Effect of ezetimibe on the in vivo kinetics of apoB-48 and apoB-100 in men with primary hypercholesterolemia.
12/2003	Postprandial hyperlipidemia: another correlate of the "hypertriglyceridemic waist" phenotype in men.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benoît Lamarche Research Topics

Disease

33	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 06/2003
22	Inflammation (Inflammations) 01/2021 - 10/2005
21	Abdominal Obesity 10/2019 - 01/2003
21	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 05/2003
19	Insulin Resistance 01/2021 - 02/2002
14	Body Weight (Weight, Body) 01/2020 - 08/2003
13	Weight Loss (Weight Reduction) 06/2021 - 10/2003
11	Type 2 Diabetes Mellitus (MODY) 11/2021 - 06/2006
10	Coronary Disease (Coronary Heart Disease) 07/2014 - 02/2002
10	Hypertriglyceridemia 01/2014 - 07/2002
9	Atherosclerosis 01/2018 - 02/2004
8	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 06/2017 - 02/2004
6	Obesity 01/2022 - 06/2002
6	Dyslipidemias (Dyslipidemia) 01/2018 - 10/2003
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 06/2004
6	Hyperlipidemias (Hyperlipidemia) 12/2017 - 11/2003
6	Myocardial Ischemia (Ischemic Heart Diseases) 10/2007 - 02/2002
5	Homozygous Familial Hypercholesterolemia 02/2018 - 08/2016
5	Hypertriglyceridemic Waist 08/2012 - 12/2003
4	Hypertension (High Blood Pressure) 11/2016 - 06/2007
4	Overweight 04/2013 - 08/2005
4	Hyperinsulinism (Hyperinsulinemia) 08/2012 - 06/2006
3	Hypercholesterolemia 08/2012 - 05/2006
2	Prostatic Neoplasms (Prostate Cancer) 07/2019 - 07/2014
2	Atherosclerotic Plaque (Atheroma) 01/2010 - 12/2009
2	Heart Diseases (Heart Disease) 01/2010 - 07/2005
1	Morbid Obesity 06/2021
1	Prehypertension 01/2021
1	COVID-19 01/2021

Drug/Important Bio-Agent (IBA)

36	oxidized low density lipoproteinIBA 01/2018 - 01/2003
30	Triglycerides (Triacylglycerol)IBA 06/2020 - 02/2002
29	Lipoproteins (Lipoprotein)IBA 01/2019 - 02/2002
19	LipidsIBA 01/2021 - 01/2003
19	ApolipoproteinsIBA 01/2018 - 10/2003
15	CholesterolIBA 01/2018 - 01/2004
14	LDL Lipoproteins (beta Lipoproteins)IBA 08/2016 - 03/2003
12	HDL CholesterolIBA 01/2019 - 02/2002
11	Insulin (Novolin)FDA Link 01/2021 - 12/2003
10	Fatty Acids (Saturated Fatty Acids)IBA 10/2020 - 01/2014
10	LDL CholesterolIBA 01/2019 - 05/2003
9	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 02/2002
8	Apolipoprotein B-100 (Apo B 100)IBA 01/2018 - 12/2003
8	Apolipoprotein B-48IBA 06/2017 - 12/2003
7	Apolipoproteins B (ApoB)IBA 01/2018 - 05/2003
6	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 06/2020 - 07/2014
6	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019 - 07/2013
6	LDL Receptors (LDL Receptor)IBA 01/2017 - 02/2004
6	Interleukin-6 (Interleukin 6)IBA 04/2013 - 10/2005
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2006
5	Monounsaturated Fatty AcidsIBA 10/2019 - 12/2010
5	CarbohydratesIBA 09/2018 - 10/2006
5	Corn Oil (Oil, Corn)IBA 01/2018 - 08/2016
5	C-Reactive ProteinIBA 04/2013 - 03/2003
4	Rapeseed OilIBA 01/2019 - 04/2014
4	Oleic Acid (Oleate)IBA 01/2018 - 07/2014
4	OilsIBA 01/2018 - 04/2014
4	Ezetimibe (Zetia)FDA Link 12/2016 - 05/2006
4	Adenosine Triphosphate (ATP)IBA 12/2013 - 08/2009
4	Trans Fatty AcidsIBA 02/2012 - 11/2003
3	FatsIBA 11/2021 - 06/2009
3	AdiponectinIBA 10/2019 - 08/2008
3	Dextran SulfateIBA 02/2018 - 08/2016
3	Lipoprotein(a)IBA 01/2018 - 03/2002
3	Docosahexaenoic AcidsIBA 08/2016 - 07/2013
3	Eicosapentaenoic AcidIBA 08/2016 - 07/2013
3	Cell Adhesion MoleculesIBA 01/2015 - 03/2008
3	Biomarkers (Surrogate Marker)IBA 11/2014 - 03/2012
3	HDL LipoproteinsIBA 01/2014 - 06/2002
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2013 - 02/2007
3	IsotopesIBA 08/2008 - 05/2006
3	Fenofibrate (CiL)FDA LinkGeneric 03/2008 - 09/2006
3	Lipase (Acid Lipase)FDA Link 06/2007 - 01/2003
2	Unsaturated Dietary FatsIBA 01/2022 - 03/2016
2	PolyphenolsIBA 01/2021 - 01/2018
2	AcidsIBA 01/2021 - 07/2014
2	Safflower Oil FDA Link 01/2018 - 07/2014
2	Plant Oils (Vegetable Oils)IBA 01/2018 - 02/2012
2	Nonesterified Fatty Acids (NEFA)IBA 01/2014 - 02/2002
2	CytokinesIBA 07/2013 - 08/2008
2	Tuberculin (PPD)IBA 12/2010 - 01/2006
2	Atorvastatin (Lipitor)FDA Link 03/2008 - 02/2008
2	Fibric Acids (Fibrates)IBA 03/2008 - 02/2008
2	Oxidoreductases (Dehydrogenase)IBA 03/2008 - 02/2008
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 06/2007 - 06/2002
2	Cholesterol Ester Transfer ProteinsIBA 06/2007 - 06/2004
2	Apolipoprotein C-IIIIBA 06/2006 - 10/2005
2	VLDL LipoproteinsIBA 05/2006 - 02/2004
2	Fibrinogen (Factor I)FDA Link 10/2005 - 03/2002
2	Conjugated Linoleic AcidsIBA 08/2005 - 01/2004
1	Stearoyl-CoA DesaturaseIBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	CitrullineIBA 01/2021
1	CelluloseIBA 01/2021
1	5'-palmitoyl cytarabine (PLAC)IBA 01/2021
1	Plant ProteinsIBA 01/2021
1	SugarsIBA 01/2021

Therapy/Procedure

9	Mediterranean Diet 03/2017 - 03/2012
4	Blood Component Removal (Apheresis) 02/2018 - 08/2016
4	Therapeutics 08/2016 - 01/2008
1	Bariatric Surgery 06/2021